OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2021.
Preliminary unaudited fourth quarter 2021 revenue is expected to be $24.8 million, up 31%, when compared to $18.9 million in the fourth quarter of 2020. Preliminary domestic revenue grew 11% while international revenue increased 363%. OrthoPediatrics’ preliminary unaudited full year 2021 revenue is expected to be $98.0 million, representing annual growth of 38%. Preliminary full year domestic revenue grew 24% while international revenue increased 150%.
The Company plans to release its fourth quarter and full year 2021 financial results in early March 2022. The quarterly and annual preliminary revenue estimates for 2021 included in this press release are prior to the completion of review and audit procedures by the Company’s independent registered public accounting firm and are therefore subject to adjustment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.